| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.41▼ | 4.42▼ | 4.44▼ | 4.49▼ | 5.38▼ |
| MA10 | 4.42▼ | 4.45▼ | 4.49▼ | 4.52▼ | 6.32▼ |
| MA20 | 4.45▼ | 4.50▼ | 4.51▼ | 5.61▼ | 4.99▼ |
| MA50 | 4.50▼ | 4.53▼ | 4.61▼ | 6.85▼ | 4.37▼ |
| MA100 | 4.51▼ | 5.28▼ | 5.68▼ | 4.67▼ | 19.14▼ |
| MA200 | 5.24▼ | 6.33▼ | 7.04▼ | 3.52▲ | 28.93▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.004▼ | 0.009▲ | -0.100▼ | 0.171▲ |
| RSI | 30.648▼ | 36.875▼ | 36.951▼ | 31.385▼ | 43.532▼ |
| STOCH | 21.429 | 21.577 | 13.175▼ | 24.210 | 26.338 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -90.426▼ | -63.554 |
| CCI | -141.001▼ | -124.522▼ | -127.915▼ | -66.392 | -89.078 |
| CDL | $APVO Marubozu Candlestick Pattern Detected | Set Alert |
|
Thursday, March 19, 2026 05:07 AM
SEATTLE, WA / ACCESS Newswire / March 19, 2026 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company developing novel immune-oncology therapeutics based on its proprietary A ...
|
|
Tuesday, March 10, 2026 10:21 AM
The clinical-stage biotechnology company announced that mipletamig, combined with venetoclax and azacitidine, delivered an 86% clinical benefit rate in newly diagnosed acute myeloid leukemia patients ...
|
|
Tuesday, March 10, 2026 05:08 AM
Frontline patient outcomes are making the case for mipletamig to enhance standard-of-care therapy alongside venetoclax + azacitidine ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/03/26 | 4.50 | 4.50 | 4.22 | 4.22 | 22,355 |
| 23/03/26 | 4.54 | 4.595 | 4.46 | 4.49 | 31,746 |
| 20/03/26 | 4.31 | 4.6699 | 4.31 | 4.56 | 29,956 |
| 19/03/26 | 4.43 | 4.63 | 4.38 | 4.50 | 34,912 |
| 18/03/26 | 4.73 | 4.73 | 4.46 | 4.67 | 27,329 |
| 17/03/26 | 4.58 | 4.67 | 4.49 | 4.63 | 29,175 |
| 16/03/26 | 4.41 | 4.7983 | 4.41 | 4.68 | 45,089 |
| 13/03/26 | 4.50 | 4.50 | 4.27 | 4.42 | 33,765 |
| 12/03/26 | 4.45 | 4.77 | 4.45 | 4.57 | 51,335 |
| 11/03/26 | 5.04 | 5.17 | 3.95 | 4.42 | 189,057 |
|
|
||||
|
|
||||
|
|